Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 28

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 8
Chunk 28
---
common shares outstanding as of December 12, 2025.

Directors and Officers

			Name and Address of Beneficial Owner (1)

			Number of Shares Beneficially Owned

			Percentage of Shares Beneficially Owned

			Joan Chypyha

			10,223

			(2)

			* 

			Sean MacDonald  

			27,162

			(3)

			* 

			Patrick Marshall

			52,325

			(4)

			* 

			Pardeep Nijhawan, MD

			1,946,138

			(5)

			19.99

			%

			David Liu

			3,664

			(6)

			* 

			Charles Olson, DSc

			10,194

			(7)

			* 

			Carlo Sistilli, CPA, CMA

			36,047

			(8)

			* 

			Michael Brooks, PhD

			163,370

			(9)

			1.9

			%

			Peter Weiler

			14,448

			(10)

			* 

			Stephen Lemieux

			30,492

			(11)

			*

			All current directors and executive officers as a group (9 persons) 

			2,263,571

			(12)

			23.6

			%

* Percentage of shares beneficially owned does not exceed one percent.

			(1)

			Unless otherwise indicated, the address of each beneficial owner is c/o Edesa Biotech, Inc., 100 Spy Court, Markham, ON Canada L3R 5H6.

			(2)

			Consists of (i) 29 common shares, (ii) 2,858 common shares issuable upon exercise of options exercisable within sixty days of December 12, 2025 and (iii) 7,336 common shares issuable upon the conversion of restricted share units that have vested or will vest within sixty days of December 12, 2025.

			(3)

			Consists of (i) 2,053 common shares, (ii) 11,773 common shares issuable upon exercise of options exercisable within sixty days